<DOC>
	<DOCNO>NCT00179023</DOCNO>
	<brief_summary>In simple term , obesity result positive balance food intake energy expenditure ( EE ) . I.e. , take energy , form food , expend , e.g. , exercise . In sedentary society , rest EE account total energy expenditure . The sympathetic nervous system ( SNS , one produce adrenaline ) think contribute rest EE . This conclusion base experiment rest EE decrease beta-blockers , high blood pressure medicine block one aspect sympathetic nervous system . The investigator propose use different approach , use medication call trimethaphan produce transient withdrawal autonomic nervous system . The investigator compare measure rest EE SNS withdraw quantify degree contribution rest EE SNS delineate difference healthy normal , healthy obese , patient autonomic dysfunction .</brief_summary>
	<brief_title>The Autonomic Nervous System Obesity</brief_title>
	<detailed_description>The rationale study even small alteration energy metabolism significantly change energy balance body weight long term . We test hypothesis sympathetic nervous system ( SNS ) activity contribute rest thermogenic component energy expenditure ( EE ) . This study divide four different part : ( 1 ) , ( 2 ) , ( 3 ) , ( 4 ) . Part ( 1 ) : gauge contribution sympathetic nervous system rest energy expenditure , blood pressure , determine difference lean , obese , patient primary autonomic failure . Part ( 2 ) : determine degree sympathetic blockade gradual infusion ganglionic blocker trimethaphan . [ Part 2 close ] Part ( 3 ) : determine energy balance patient primary autonomic failure . Part ( 4 ) : determine contribution sympathetic nervous system lipolysis . [ Part 4 close ] Subjects selections* : For part ( 1 ) ( 2 ) study six group subject ( n = 40 group ) : patient pure autonomic failure , patient multiple system atrophy , healthy normal control ( BMI &lt; = 25 ) , obese control ( BMI 30-40 ) obese hypertensive ( BMI 30-40 ) lean hypertensive ( BMI 20-28 ) . A time interval least 1 week require subject wish participate part ( 1 ) part ( 2 ) . For part ( 3 ) study two group subject ( n=12 group ) : patient autonomic failure , age sex-matched sedentary , healthy control . For part ( 4 ) study two group subject ( n=12 group ) : healthy normal control ( BMI 20-25 ) , obese control ( BMI 30-40 ) . *Part 2 4 close .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Pure Autonomic Failure</mesh_term>
	<mesh_term>Shy-Drager Syndrome</mesh_term>
	<mesh_term>Multiple System Atrophy</mesh_term>
	<mesh_term>Trimethaphan</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<mesh_term>Trimethaphan camsylate</mesh_term>
	<mesh_term>Pseudoephedrine</mesh_term>
	<criteria>Healthy normal ( BMI &lt; = 25 Kg/m2 ) , obese ( BMI 30 40 ) volunteer , lean hypertensive ( BMI 2028 Kg/m2 ) , obese hypertensive ( BMI 30 40 ) Ages 1860 Patients pure autonomic failure multiple system atrophy age 1880 , refer service diagnosis treatment condition , age sexmatched sedentary , healthy control age 1880 Exclusion criterion : All medical student Pregnant woman Heart failure , symptomatic coronary artery disease , liver impairment , history stroke myocardial infarction , glaucoma History serious allergy asthma Subjects use betablockers</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>OBESITY</keyword>
	<keyword>RESTING ENERGY EXPENDITURE</keyword>
	<keyword>SYMPATHETIC NERVOUS SYSTEM</keyword>
	<keyword>HYPERTENSION</keyword>
	<keyword>AUTONOMIC FAILURE</keyword>
</DOC>